PSYCHNOSTICS LLC has a total of 18 patent applications. It decreased the IP activity by 50.0%. Its first patent ever was published in 2006. It filed its patents most often in United States, Canada and WIPO (World Intellectual Property Organization). Its main competitors in its focus markets measurement, biotechnology and pharmaceuticals are NeuroDiagnostics LLC, BOSTON HEART DIAGNOSTICS CORP and AURELIUM BIOPHARMA INC.
# | Country | Total Patents | |
---|---|---|---|
#1 | United States | 7 | |
#2 | Canada | 5 | |
#3 | WIPO (World Intellectual Property Organization) | 5 | |
#4 | EPO (European Patent Office) | 1 |
# | Industry | |
---|---|---|
#1 | Measurement | |
#2 | Biotechnology | |
#3 | Pharmaceuticals | |
#4 | Computer technology | |
#5 | Organic fine chemistry |
# | Technology | |
---|---|---|
#1 | Analysing materials | |
#2 | Medical preparations | |
#3 | Measuring microorganism processes | |
#4 | Combinatorial chemistry | |
#5 | Microorganisms | |
#6 | Healthcare informatics |
# | Name | Total Patents |
---|---|---|
#1 | Thiruvengadam Alagu P | 18 |
#2 | Chandrasekaran Krish | 5 |
#3 | Woodruff Douglas B | 3 |
Publication | Filing date | Title |
---|---|---|
WO2019089319A1 | Combination therapies for treating bipolar disorder and adhd, and methods for using the same | |
EP3538888A2 | Combination therapies for treating bipolar disorder, and methods for using the same | |
US2016084826A1 | Methods for treating ADHD and bipolar disorder using a membrane potential ratio test | |
CA2901127A1 | Genes expressed in mental illness and mood disorders | |
WO2013052258A1 | Methods for diagnosing and identifying modulators of membrane potentials in bipolar disorder and attention deficit hyperactivity disorder | |
US2008160554A1 | Methods for diagnosing an attention-deficit/Hyperactivity disorder |